'Pfizer is planning to test a daily weight-loss pill in mid-stage trials later this year, as the struggling pharmaceutical group pins its hope on the experimental drug as its route into a market projected to be worth more than $130bn a year.'
https://www.ft.com/content/865f8432-6c88-40ca-a48e-06b30a81f176
Thiago Carvalho /
npub1xa…czham
2024-07-12 08:55:54
Author Public Key
npub1xakev87fgm9edqu6f5jhszwunekjxl3dpnq4sxvm3nzu2ace8xnqyczhamPublished at
2024-07-12 08:55:54Event JSON
{
"id": "1fdaba863e897aecc76d0bf7285baa6b6832c60f8b316d990bd42b4981a72c6d",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1720774554,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/112772681222407735",
"activitypub"
]
],
"content": "'Pfizer is planning to test a daily weight-loss pill in mid-stage trials later this year, as the struggling pharmaceutical group pins its hope on the experimental drug as its route into a market projected to be worth more than $130bn a year.'\n\nhttps://www.ft.com/content/865f8432-6c88-40ca-a48e-06b30a81f176",
"sig": "a48038e1ec0a3c0f26dcb3a7b6ea7a0bed823fefab3bdd6b8f24fb8ac256422d3af485c68e055b73fb254989d535187069e9625852a79c961864c7cf871b19e7"
}